0001209191-19-061657.txt : 20191220 0001209191-19-061657.hdr.sgml : 20191220 20191220194453 ACCESSION NUMBER: 0001209191-19-061657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Starling William N JR CENTRAL INDEX KEY: 0001324130 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 191303213 MAIL ADDRESS: STREET 1: 2300 BUCKSKIN ROAD CITY: POCATELLO STATE: ID ZIP: 83201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-19 0 0000876378 TRANSENTERIX, INC. TRXC 0001324130 Starling William N JR 345 GOLDEN HILLS DRIVE PORTOLA VALLEY CA 94028 1 0 0 0 Common Stock 2019-12-19 4 S 0 3587 1.39 D 17983 I See Footnote Common Stock 2019-12-19 4 S 0 6015 1.44 D 11968 I See Footnote Common Stock 18134 I See Footnote Common Stock 131102 I See Footnote Common Stock 1568 D Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990. Reflects a reverse stock split of the Registrant's common stock at a ratio of one-for-thirteen with marketplace effectiveness on December 12, 2019 whereby the resulting fractional share was rounded up to the nearest whole share. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.44 to $1.445 inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Shares of Common Stock held by Synecor, L.L.C. Willam N. Starling is the chief executive officer of Synecor, L.L.C. Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P. /s/ Joshua Weingard attorney-in-fact for William N. Starling, Jr. 2019-12-20